Neola Medical AB (publ) (STO:NEOLA)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.160
+0.020 (1.75%)
May 25, 2026, 5:29 PM CET

Neola Medical AB Balance Sheet

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
9.9616.1219.5621.5840.0922.94
Cash & Short-Term Investments
9.9616.1219.5621.5840.0922.94
Cash Growth
-69.52%-17.55%-9.38%-46.17%74.76%37.80%
Accounts Receivable
1.161.11----
Other Receivables
--1.0720.91.021.45
Receivables
1.161.111.0720.91.021.45
Prepaid Expenses
--0.420.630.490.4
Other Current Assets
-----0-
Total Current Assets
11.1117.2421.0443.1141.624.79
Property, Plant & Equipment
0.20.220.20.140.220.16
Other Intangible Assets
63.84-----
Long-Term Deferred Charges
-61.2252.3742.7833.5118.88
Other Long-Term Assets
0.150.13---0
Total Assets
75.378.873.6186.0275.3343.83
Accounts Payable
--1.072.181.491.3
Accrued Expenses
1.721.5621.621.791.44
Current Income Taxes Payable
--0.10.090.080.05
Other Current Liabilities
1.341.441.492.271.980.41
Total Current Liabilities
3.0734.656.165.353.19
Other Long-Term Liabilities
---0.832.5-
Total Liabilities
3.0734.656.997.853.19
Common Stock
72.2375.85.013.983.981.5
Additional Paid-In Capital
--99.0880.1179.5644.83
Retained Earnings
---35.13-25.06-16.05-5.7
Comprehensive Income & Other
---20--
Shareholders' Equity
72.2375.868.9679.0367.4940.63
Total Liabilities & Equity
75.378.873.6186.0275.3343.83
Net Cash (Debt)
9.9616.1219.5621.5840.0922.94
Net Cash Growth
-69.52%-17.55%-9.38%-46.17%74.76%37.80%
Net Cash Per Share
-0.210.280.391.541.64
Filing Date Shares Outstanding
-77.9570.1570.1555.6921.05
Total Common Shares Outstanding
-77.9570.1555.6955.6921.05
Working Capital
8.0414.2416.3936.9536.2621.59
Book Value Per Share
-0.970.981.421.211.93
Tangible Book Value
8.3975.868.9679.0367.4940.63
Tangible Book Value Per Share
-0.970.981.421.211.93
Machinery
--0.460.310.310.2
Source: S&P Global Market Intelligence. Standard template. Financial Sources.